RFCA
BDSI

R&F Capital Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

R&F Capital Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-16,105
Closed -$28K – 907
2016
Q4 		$28K Buy
+16,105
New +$32.9K 0.01% 483

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 42.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

R&F Capital Advisors's BDSI Position: Q1 2017 in Review

R&F Capital Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2017, closing a stake of 16,105 shares — an estimated $28K sold.

R&F Capital Advisors first reported a position in BDSI in Q4 2016 and held it in 1 quarter. The position peaked at $28K in Q4 2016. 63 funds tracked by Wall St. Rank hold BDSI as of Q1 2017.

  • R&F Capital Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2017 after selling out during the quarter.
  • R&F Capital Advisors sold 16,105 BioDelivery Sciences International, Inc. shares in Q1 2017, an estimated $28K.
  • R&F Capital Advisors first reported a position in BioDelivery Sciences International, Inc. in Q4 2016 and held it in 1 quarter.
  • R&F Capital Advisors's BioDelivery Sciences International, Inc. position peaked at $28K in Q4 2016.
  • 63 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.